102 results
424B4
BBLG
Bone Biologics Corp
4 Mar 24
Prospectus supplement with pricing info
5:21pm
stage entity. The production and marketing of our products and ongoing research and development activities are subject to extensive regulation … continued development has been funded through capital raises. Our research and development expenses for the years ended December 31, 2023 and 2022 were
424B5
8vppe y7704i
20 Nov 23
Prospectus supplement for primary offering
7:44am
424B4
bsbl 38wq
15 Jun 23
Prospectus supplement with pricing info
8:25pm
424B4
u51nlv1 ff
11 Oct 22
Prospectus supplement with pricing info
10:57am